One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Prognostic Value of Cardiovascular Biomarkers in the Population
Johannes Tobias Neumann, MD, PhD1,2,3,4; Raphael Twerenbold, MD1,2,3; Jessica Weimann, MSc1,2; Christie M. Ballantyne, MD5; Emelia J. Benjamin, MD, ScM6,7; Simona Costanzo, PhD8; James A. de Lemos, MD9; Christopher R. deFilippi, MD10; Augusto Di Castelnuovo, PhD11; Chiara Donfrancesco, PhD12; Marcus Dörr, MD13,14; Kai M. Eggers, MD15; Gunnar Engström, MD, PhD16; Stephan B. Felix, MD13,14; Marco M. Ferrario, MD, PhD17; Ron T. Gansevoort, MD18; Simona Giampaoli, MD19; Vilmantas Giedraitis, PhD20; Pär Hedberg, MD, PhD21; Licia Iacoviello, MD, PhD8,22; Torben Jørgensen, MD23,24; Frank Kee, MD25; Wolfgang Koenig, MD26,27,28; Kari Kuulasmaa, PhD29; Joshua R. Lewis, PhD30,31,32; Thiess Lorenz, MA1,2; Magnus N. Lyngbakken, MD, PhD33,34; Christina Magnussen, MD1,2,3; Olle Melander, PhD15; Matthias Nauck, MD14,35; Teemu J. Niiranen, MD29,36,37; Peter M. Nilsson, MD15; Michael H. Olsen, MD38,39; Torbjorn Omland, MD, PhD33,34; Viktor Oskarsson, MD, PhD40; Luigi Palmieri, PhD12; Anette Peters, PhD28,41,42; Richard L. Prince, MD30,31; Vazhma Qaderi, MD1,2; Ramachandran S. Vasan, MD6,43; Veikko Salomaa, MD29; Susana Sans, MD44; J. Gustav Smith, MD45; Stefan Söderberg, MD, PhD40; Barbara Thorand, PhD41,42; Andrew M. Tonkin, MD4; Hugh Tunstall-Pedoe, MD46; Giovanni Veronesi, PhD17; Tetsu Watanabe, MD47; Masafumi Watanabe, MD47; Andreas M. Zeiher, MD48,49; Tanja Zeller, PhD1,2,3; Stefan Blankenberg, MD1,2,3; Francisco Ojeda, PhD1,2
doi : 10.1001/jama.2024.5596
June 11, 2024, Vol 331, No. 22, Pages 1875-1974
Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening
Xiaoshuang Feng, PhD1; Hana Zahed, PhD1; Justina Onwuka, PhD1; Matthew E. J. Callister, PhD2,3; Mattias Johansson, PhD1; Ruth Etzioni, PhD4,5; Hilary A. Robbins, PhD, MHS, MSPH1
doi : 10.1001/jama.2024.5814
Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024
Yan Xie, PhD1; Taeyoung Choi, MS1; Ziyad Al-Aly, MD1
doi : 10.1001/jama.2024.7395
Screening for Breast Cancer
Jillian T. Henderson, PhD, MPH1; Elizabeth M. Webber, MS1; Meghan S. Weyrich, MPH2; Marykate Miller, MS2; Joy Melnikow, MD, MPH2
doi : 10.1001/jama.2023.25844
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies
Amy Trentham-Dietz, PhD, MS1; Christina Hunter Chapman, MD, MS2; Jinani Jayasekera, PhD, MS3; Kathryn P. Lowry, MD4; Brandy M. Heckman-Stoddard, PhD, MPH5; John M. Hampton, MS1; Jennifer L. Caswell-Jin, MD6; Ronald E. Gangnon, PhD1,7; Ying Lu, PhD, MS8; Hui Huang, MS9; Sarah Stein, PhD10; Liyang Sun, MS8; Eugenio J. Gil Quessep, MS11; Yuanliang Yang, MS12; Yifan Lu, BASc13; Juhee Song, PhD12; Diego F. Muñoz, PhD8; Yisheng Li, PhD, MS12; Allison W. Kurian, MD, MSc14; Karla Kerlikowske, MD15; Ellen S. O’Meara, PhD16; Brian L. Sprague, PhD17; Anna N. A. Tosteson, ScD18; Eric J. Feuer, PhD19; Donald Berry, PhD12; Sylvia K. Plevritis, PhD20; Xuelin Huang, PhD12; Harry J. de Koning, MD, PhD11; Nicolien T. van Ravesteyn, PhD11; Sandra J. Lee, ScD9; Oguzhan Alagoz, PhD, MS13; Clyde B. Schechter, MD, MA21; Natasha K. Stout, PhD10,19; Diana L. Miglioretti, PhD, ScM16,22; Jeanne S. Mandelblatt, MD, MPH23
doi : 10.1001/jama.2023.24766
The State of State Biomarker Testing Insurance Coverage Laws
Grace A. Lin, MD, MAS1,2; Janet M. Coffman, PhD2; Kathryn A. Phillips, PhD1,2
doi : 10.1001/jama.2024.6058
Can Cardiovascular Risk Assessment Be Improved in the 21st Century?
Thomas A. Gaziano, MD, MSc1; J. Michael Gaziano, MD, MPH2
doi : 10.1001/jama.2024.7644
Late-Stage Cancer End Points to Speed Cancer Screening Clinical Trials—Not So Fast
Peter B. Bach, MD, MAPP1
doi : 10.1001/jama.2024.5821
Toward More Equitable Breast Cancer Outcomes
Joann G. Elmore, MD, MPH1; Christoph I. Lee, MD, MS2,3,4
doi : 10.1001/jama.2024.6052
“Inoculation� to Resist Misinformation
Sander van der Linden, PhD1; Jon Roozenbeek, PhD1,2
doi : 10.1001/jama.2024.5026
Despite New Recommendations, the Debate Over Mammography Guidelines Continues
Rita Rubin, MA1
doi : 10.1001/jama.2024.1279
Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available
Rita Rubin, MA1
doi : 10.1001/jama.2024.7370
Antipsychotics for Dementia Tied to More Serious Harms Than Expected
Emily Harris
doi : 10.1001/jama.2024.8421
WHO Updates Terminology for Pathogens That Spread Through the Air
Emily Harris
doi : 10.1001/jama.2024.8422
Pregnancy Complications Tied to Higher Risk of Death Decades Later
Emily Harris
doi : 10.1001/jama.2024.8423
Urine-Based Test Could Help Identify Aggressive Prostate Cancer
Emily Harris
doi : 10.1001/jama.2024.8424
New HHS Rule Strengthens Privacy Around US Reproductive Care
Emily Harris
doi : 10.1001/jama.2024.8425
Changes to Medicare, Medicaid Coverage Could Cause Thousands of Deaths
Emily Harris
doi : 10.1001/jama.2024.8426
CMS Finalizes Staffing Minimum Requirements for Nursing Homes
Emily Harris
doi : 10.1001/jama.2024.8427
Autoantibody Profile Emerged Years Before Multiple Sclerosis Diagnosis
Emily Harris
doi : 10.1001/jama.2024.8428
Patients Treated by Female Physicians Had Better Mortality Rates
Emily Harris
doi : 10.1001/jama.2024.8429
Apixaban to Prevent Recurrence After Cryptogenic Stroke
Kuan-Yu Chi, MD1; Michele Nanna, MD2; Michael G. Nanna, MD, MHS3
doi : 10.1001/jama.2024.6851
Apixaban to Prevent Recurrence After Cryptogenic Stroke
Gianluca Rigatelli, MD, PhD1; Marco Zuin, MD, MS2
doi : 10.1001/jama.2024.6845
Apixaban to Prevent Recurrence After Cryptogenic Stroke
Xin Wen, MMed1; Jianyun Yan, PhD1; Zhaohua Zhu, PhD1
doi : 10.1001/jama.2024.6848
Apixaban to Prevent Recurrence After Cryptogenic Stroke—Reply
Hooman Kamel, MD1; David L. Tirschwell, MD2; Mitchell S. V. Elkind, MD3; for the ARCADIA Investigators
doi : 10.1001/jama.2024.6855
AI-Generated Clinical Summaries
Charlaine Chen, BS1; Joseph E. Thornton, MD1
doi : 10.1001/jama.2024.7277
AI-Generated Clinical Summaries—Reply
Katherine E. Goodman, PhD, JD1; Daniel J. Morgan, MD, MS2
doi : 10.1001/jama.2024.7280
